UNSPSC 51384529: Ketoprofen lysine

This classification denotes a nonsteroidal antiinflammatory drug C16H14O3.C6H14N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5WD00E3D4C, chemically known as l-lysine, 3-benzoyl-.alpha.-methylbenzeneacetate (1:1), but more generally known as ketoprofen lysine, which bears US NIH Compound Identifier 119285. European Medicines Agency schedules Ketoprofen lysine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02834MIG.

Most nations, for tariff and trade purposes, schedule ketoprofen lysine under HS 29183000 and SITC 51395. As of Q4 2014, KETOPROFEN LYSINE remains US FDA's Preferred Term for this commodity. SMILES: CC(C1CCCC(C1)C(=O)C2CCCCC2)C(=O)O.C(CCN)C[C@@H](C(=O)O)N.

UNSPSC 51384529 Ketoprofen lysine is a Commodity code that in recent state and local procurement does not align with active buying activity; the three recent opportunities tagged under this code—naloxone procurement, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products—do not reflect ketoprofen lysine acquisition. Seminole County, Florida's IFB60459723LAS solicited naloxone and drug deactivation systems rather than ketoprofen formulations; Texas Health and Human Services Commission's RFI HHS0017013 explored direct-to-manufacturer prescription program structures without naming ketoprofen; and the Minnesota Multistate Cooperative Purchasing Alliance's MMCAP RFP S1070000015802 sought generic multi-source pharmaceuticals and OTC products through authorized wholesalers on a broader therapeutic basis. The code shows little relevant recent activity as currently tagged in state and local procurement systems.

The issuing bodies in recent opportunities span state agencies and cooperative purchasing vehicles—Seminole County (Florida), Texas HHS Commission, and the Minnesota Department of Administration's MMCAP cooperative serving multiple states including Oregon—but the pharmaceutical products actually being procured do not correspond to ketoprofen lysine formulations. Geographic activity appears distributed across Florida, Texas, and the Upper Midwest through cooperative arrangements, yet the mismatch between the code's nominal scope and the work actually being bought suggests that ketoprofen lysine may be classified or sourced under different UNSPSC codes within state and local systems, or that demand for this specific formulation is not presently driving standalone procurement activity at the state or local level.